Eculizumab withdrawal and monitoring in atypical haemolytic uraemic syndrome (SETS aHUS): a multicentre, open label, prospective, single arm trial
Luke Vale, David Walbaum, Giovany Orozco-Leal, Michal Malina et al.
Citations
3 citations
Journal
The Lancet Regional Health - Europe
Topics
Complement system in diseases
Field-Weighted Citation Impact (FWCI)
2.39
article
Eculizumab withdrawal and monitoring in atypical haemolytic uraemic syndrome (SETS aHUS): a multicentre, open label, prospective, single arm trial
Luke Vale, David Walbaum, Giovany Orozco-Leal, Michal Malina, Chris Weetman, Neil Sheerin, Jan Lecouturier, Edwin Wong, Ciara Kennedy, David Kavanagh, Emma Montgomery, Victoria Brocklebank, Nicholas Torpey, Sally Johnson, Tina Dutt, Mordi Muorah, Thomas Chadwick, Andrew Bryant, Sonya Carnell, Yemi Oluboyede, Daniel P. Gale, Ravindra Rajakariar, Michael E. Kelly, Stephen D. Marks, C R Muirhead, Mark Uniake, Pallavi Yadav, Amrit Kaur, Sarah Dunn, Coralie Bingham, Paramit Chowdhury, Eric Finlay
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Regional Health - EuropeVol. 56
Institutions
Newcastle upon Tyne Hospitals NHS Foundation Trust (GB), London School of Hygiene & Tropical Medicine (GB), Newcastle University (GB)